![]() ![]() Both monetary and societal cost associated with AF can be minimized by utilizing the safest and most effective treatments, but technological advances frequently outpace the evidence that is needed for informed decision-making. ![]() The projected total cost of medical and indirect treatment for AF in 2019 is $35.7 billion according to a 2016 report commissioned by the American Heart Association. Increased risk of complication was attributable to low-volume sites and baseline patient characteristics. ConclusionĪcute ablation-related complication rates were low and were not significantly associated with catheter technology. Neither ablation catheter nor AF type was statistically significant after controlling for site volume, patient age, and comorbid conditions (ST vs. 7.3%), as did ablations with ST compared with CB2 within each AF type (PAF 6.0% vs. Ablations for paroxysmal AF (PAF) had a lower complication rate than ablations for persistent AF (PsAF) (6.1% vs. In total, 1473 ablations met all inclusion criteria (407 ST, 1066 CB2). The primary outcome was a composite safety endpoint of acute ablation-related complications defined via ICD-10 diagnosis and procedure codes, including tamponade and other pericardial events, respiratory complications, stroke, cerebral or pre-cerebral occlusion/stenosis without infarction, vascular access complications, hemorrhage, phrenic nerve injury, myocardial infarction, and pulmonary embolism. The Vizient Health Systems database, a large US hospital database, was used to compare acute complications in AF ablation with the contact force sensing THERMOCOOL SMARTTOUCH® Catheter or the THERMOCOOL SMARTTOUCH® SF Catheter (ST) versus the second-generation Arctic Front Advance™ Cryoablation Catheter (CB2) between September 2015 and June 2017. The objective of this study was to compare real-world safety outcomes with the latest catheter technologies used for the treatment of atrial fibrillation (AF). Real-world data can help medical administrators, physicians, and payers make evidence-based decisions regarding treatment choices. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |